Cas:146013-28-7 N-tert-butyl-5-(2-methylpropyl)thiophene-2-sulfonamide manufacturer & supplier

Chemical Name:N-tert-butyl-5-(2-methylpropyl)thiophene-2-sulfonamide

CAS.NO:146013-28-7

Synonyms:2-Thiophenesulfonamide,N-(1,1-dimethylethyl)-5-(2-methylpropyl);N-(tert-Butyl)-5-isobutylthiophene-2-sulfonamide;5-isobutyl-N-tert-butylthiophene-2-sulfonamide;N-(tert-butyl)-5-isobutylthiophene-2-sulphonamide;5-isobutyl-2-(N-t-butylaminosulfonyl)thiophene

Molecular Formula:C₁₂H₂₁NO₂S₂

Molecular Weight:275.43100

HS Code:2935009090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:82.79000

Exact Mass:275.10100

LogP:4.49510

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Thiophenesulfonamide,N-(1,1-dimethylethyl)-5-(2-methylpropyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-isobutyl-2-(N-t-butylaminosulfonyl)thiophene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(tert-butyl)-5-isobutylthiophene-2-sulphonamide Use and application,5-isobutyl-2-(N-t-butylaminosulfonyl)thiophene technical grade,usp/ep/jp grade.

Related News: With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines. N-tert-butyl-5-(2-methylpropyl)thiophene-2-sulfonamide manufacturer Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. N-tert-butyl-5-(2-methylpropyl)thiophene-2-sulfonamide supplier With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines. N-tert-butyl-5-(2-methylpropyl)thiophene-2-sulfonamide vendor Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. N-tert-butyl-5-(2-methylpropyl)thiophene-2-sulfonamide factory ��Once these risks have been identified then a project team can be put together combining the necessary expertise to provide the integrated services and tailored support to ensure continuity of supply from beginning to end.��